This website uses cookies to enhance the user experience.
LP

Lars Petter Waldø-Jensen1959

Shareholdings
1
9
Norway Business roles
16

Roles

Management

NameRoleTotal operating incomeTotal equityShares
N
NICOMAX AS
Managing Director/CEO
-
14,703,000
45 %
directly
W
WAMALINO GROUP AS
Managing Director/CEO
6,538,491
39,210,419
16.2 %
indirectly

Boards

NameRoleTotal operating incomeTotal equityShares
N
NICOMAX AS
Chairman
-
14,703,000
45 %
directly
E
ENDOTECH INVEST AS
Chairman
-
24,729
27 %
indirectly
U
UTHUSSETRA 9 AS
Chairman
-
-163,964
22.5 %
indirectly
D
DATA-SECURE AS
Contact Person
1,907,466
-181,241
21.35 %
indirectly
N
NORDIC MEDICAL GROUP AS
Contact Person
-
30,854,620
16.2 %
indirectly
W
WAMALINO GROUP AS
Board Member
6,538,491
39,210,419
16.2 %
indirectly
E
ENDOTECH AS
Chairman
79,469,946
7,029,932
15.39 %
indirectly
E
ET INNOVASJON AS
Board Member
-
971,452
10.85 %
indirectly
N
NEORESQ AS
Board Member
200,000
46,542
7.93 %
indirectly
M
MABSEMBALLASJE AS
Board Member
13,504,197
90,000
-
N
NDS SECURITY AS
Chairman
25,998,338
694,428
-
F
FBS ENTREPRENØR AS
Board Member
11,425,712
-1,715,313
-
Last update: Jul 26, 2024

Shares owned by Lars Petter Waldø-Jensen

NameShare classTotal operating incomeTotal equityShare
N
NICOMAX AS
Ordinære aksjer
0
14,703,000
45 %
directly
E
ENDOTECH INVEST AS
0
24,729
27 %
indirectly
U
UTHUSSETRA 9 AS
0
-163,964
22.5 %
indirectly
D
DATA-SECURE AS
1,907,466
-181,241
21.35 %
indirectly
N
NORDIC MEDICAL GROUP AS
0
30,854,620
16.2 %
indirectly
W
WAMALINO GROUP AS
6,538,491
39,210,419
16.2 %
indirectly
E
ENDOTECH AS
79,469,946
7,029,932
15.39 %
indirectly
E
ET INNOVASJON AS
0
971,452
10.85 %
indirectly
N
NEORESQ AS
200,000
46,542
7.93 %
indirectly
N
NIKKIMED AS
0
15,551
4.05 %
indirectly

Limited to direct ownership positions of 0.5% or more.

Last update: Jun 2, 2025